Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kintor Pharmaceutical Ltd ( (HK:9939) ) just unveiled an update.
Kintor Pharmaceutical Ltd has officially commenced the global sales of KT-939, a self-developed functional raw material for whitening and freckle-removing cosmetics. This move marks the company’s entry into the functional cosmetic raw material industry, forming a ‘troika’ business model alongside its R&D and B2C operations. KT-939, a tyrosinase inhibitor, has demonstrated superior efficacy and safety compared to existing compounds, and has received international compliance approvals, paving the way for its global market expansion.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Ltd is a company in the pharmaceutical industry, focusing on the development of innovative topical drugs and functional cosmetic products. They have recently expanded into the functional cosmetic raw material industry, aiming to provide high-quality and safe cosmetic raw materials for the global market.
Average Trading Volume: 3,944,025
Technical Sentiment Signal: Hold
Current Market Cap: HK$568M
See more data about 9939 stock on TipRanks’ Stock Analysis page.